Q-State Biosciences
Chad Martinson currently serves as CEO of ACOVA Integrated Health, a company dedicated to delivering better health outcomes for individuals living with chronic conditions. As CEO, Chad directs ACOVA’s long-term growth planning by building strong industry relationships and sourcing new business development opportunities that compliment and add value to the company. Chad currently also serves as Director of Q-State Biosciences, Pairnomix, Proximagen, MOBE and Plymouth Guarantee. Prior to joining ACOVA, Chad held a number of leadership roles in the fields of corporate finance, business unit finance, sales and marketing, and operations. Most recently, Chad served as CFO and Executive Vice President of Operations at Upsher-Smith Laboratories and Director of Pairnomix. He also previously served as VP of Finance and Business Development at Medtronic in the company’s neuro division, and spent eight years at KPMG in the audit practice. He holds a B.A. from Luther College in Decorah, Iowa, and an M.B.A. from Harvard Business School in Boston, Massachusetts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Q-State Biosciences
Q-State Biosciences is a technology-derived medicines company based in Cambridge, MA, that combines advanced human cellular models, unique measurement engineering, and AI/machine learning into a proprietary platform that enables novel discovery of optimized genetically targeted medicines for epilepsy, pain, and other diseases of the CNS.